Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 4,928 | 12,068 | 54,735 | 40,772 | 26,077 |
Receivables | N/A | 73 | 17 | 20 | 26 |
TOTAL | $5,378 | $13,290 | $55,728 | $42,596 | $26,966 |
Non-Current Assets | |||||
TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
Total Assets | $5,378 | $13,290 | $55,728 | $42,596 | $26,966 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 18,300 | 21,603 | 25,982 | 7,217 | 8,119 |
Other current liabilities | 125 | 11,170 | N/A | N/A | N/A |
TOTAL | $18,425 | $32,773 | $25,982 | $7,217 | $8,119 |
Non-Current Liabilities | |||||
TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
Total Liabilities | $18,425 | $32,773 | $25,982 | $7,217 | $8,119 |
Shareholders' Equity | |||||
Shares Outstanding, K | 35,686 | 12,947 | 9,059 | 7,521 | 5,504 |
Common Shares | 3 | 1 | 1 | 7 | 6 |
Retained earnings | -314,333 | -262,486 | -199,862 | -143,192 | -120,111 |
Other shareholders' equity | 3,419 | 1,885 | 6,598 | 4,617 | 2,510 |
TOTAL | $-13,047 | $-19,483 | $29,746 | $35,379 | $18,847 |
Total Liabilities And Equity | $5,378 | $13,290 | $55,728 | $42,596 | $26,966 |